Quarterly report pursuant to Section 13 or 15(d)

Shareholders' Deficit (Details 2)

v3.19.3
Shareholders' Deficit (Details 2) - Warrants [Member]
9 Months Ended
Sep. 30, 2019
USD ($)
$ / shares
shares
Number of Warrants  
Balance Outstanding, Beginning | shares
Granted | shares 1,750,000
Cancelled | shares
Balance Outstanding, Ending | shares 1,750,000
Exercisable | shares 1,750,000
Weighted Average Exercise Price  
Balance Outstanding, Beginning | $ / shares
Granted | $ / shares 0.09
Cancelled | $ / shares
Balance Outstanding, Ending | $ / shares 0.09
Exercisable | $ / shares $ 0.09
Weighted Average Remaining Contractual Term (Years)  
Balance Outstanding, Beginning
Balance Outstanding, Ending 4 years 10 months 3 days
Exercisable 4 years 10 months 3 days
Aggregate Intrinsic Value  
Balance Outstanding, Beginning | $
Balance Outstanding, Ending | $ 0
Exercisable | $ $ 0